INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $417,150 | +72.9% | 22,500 | +3.1% | 0.00% | – |
Q2 2023 | $241,330 | -84.1% | 21,820 | -80.7% | 0.00% | -100.0% |
Q1 2023 | $1,521,900 | +249.1% | 113,321 | +322.3% | 0.00% | +200.0% |
Q1 2022 | $436,000 | -34.8% | 26,836 | -34.6% | 0.00% | 0.0% |
Q4 2021 | $669,000 | -59.1% | 41,028 | -62.7% | 0.00% | -85.7% |
Q3 2021 | $1,635,000 | -7.7% | 110,085 | +43.5% | 0.01% | -12.5% |
Q1 2021 | $1,772,000 | -2.3% | 76,723 | +4.5% | 0.01% | -20.0% |
Q4 2020 | $1,814,000 | +13.2% | 73,433 | +90.1% | 0.01% | 0.0% |
Q3 2020 | $1,602,000 | +5.3% | 38,628 | +186.9% | 0.01% | -86.3% |
Q1 2017 | $1,521,000 | -86.3% | 13,463 | -86.8% | 0.07% | 0.0% |
Q4 2016 | $11,121,000 | +85.3% | 102,360 | +180.7% | 0.07% | +69.8% |
Q3 2016 | $6,002,000 | -61.5% | 36,468 | -66.6% | 0.04% | -67.2% |
Q2 2016 | $15,570,000 | +3607.1% | 109,127 | +3241.3% | 0.13% | +3175.0% |
Q1 2016 | $420,000 | -67.9% | 3,266 | -58.7% | 0.00% | -75.0% |
Q3 2015 | $1,310,000 | +452.7% | 7,900 | +690.0% | 0.02% | +433.3% |
Q2 2014 | $237,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |